# How Biotech Writers Organize Medical Conference Coverage

Canonical URL: https://biopharmsignal.com/use-cases/biotech-newsletter-writers/medical-conference-coverage-workflow
Role: [Biotech Newsletter Writers](https://biopharmsignal.com/use-cases/biotech-newsletter-writers.md)
Category: Conference coverage
Last updated: 2026-07-26

Separate the conference news cycle into stages so coverage remains selective, accurate, and connected.

## The Situation

ASCO, AACR, ESMO, ASH, or another major meeting produces hundreds of abstracts, presentations, company releases, and follow-up comments in a short period.

### Best Fit

Independent writers, newsletter teams, financial media creators, podcasters, and editors covering biotechnology and pharmaceutical companies.

## The Challenge

The team cannot cover everything and risks confusing encore data, trial-design posters, preliminary updates, and genuinely new clinical evidence.

## How To Think About The Task

Medical conferences are multi-stage information events. Abstract release, company commentary, presentation day, competitor reaction, and post-conference plans may each add different evidence. Treating the meeting as one news burst creates duplication and missed context.

A small editorial team should narrow the field before the conference and assign different coverage goals to each stage.

### Build the watchlist before abstracts

Select companies and programs based on audience interest, expected new evidence, and competitive relevance. Record prior data so the team can identify what actually changes.

### Classify rather than hype abstracts

Label new data, updated follow-up, subgroup analyses, encore data, trial design, and exploratory work separately. The classification determines how much editorial attention the item deserves.

### Plan the post-conference story

The most important consequence may be a Phase 3 plan, FDA discussion, partnership, financing, or change in competitive positioning. Schedule follow-up instead of ending coverage with the presentation.

## Illustrative Example

### Illustrative oncology meeting workflow

A team selects fifteen programs before abstracts. Five abstracts contain genuinely new or updated clinical evidence, three require presentation-day coverage, and two create competitive read-through stories.

After the meeting, the team publishes one synthesis focused on what changed in the treatment landscape rather than dozens of disconnected recaps.

### Questions To Answer Before Making A Decision

- Is the data new, updated, exploratory, or encore?
- What changed from the previous data cut?
- Which competitor programs are affected?
- What development action should follow the presentation?

## A Repeatable Workflow

1. Build a pre-conference company and program watchlist tied to audience interests.
2. Classify abstracts as new data, updated data, encore data, trial design, or exploratory analysis.
3. Create presentation-day checklists for patient count, follow-up, efficacy, safety, and prior-data comparison.
4. Track read-through across companies in the same target or indication.
5. Schedule post-conference follow-up for next steps, management clarification, and regulatory implications.

## Signals To Keep Visible

- Abstract release and embargo rules
- Poster and oral presentation timing
- Changes from prior data cuts
- Company press releases and source materials
- Post-conference development plans

## Common Mistakes

- Treating every abstract as new catalyst data
- Comparing presentations without matching follow-up and population
- Ending coverage when the presentation ends

## Deliverable

A staged editorial plan covering pre-conference previews, presentation-day updates, competitive synthesis, and post-meeting follow-up.

## Practical Outcome

The publication covers fewer but more consequential stories and gives readers continuity across the full conference information cycle.

## Where BioPharmSignal Fits

Use LiveFeed and company pages for source-linked monitoring, the PDUFA Calendar for upcoming FDA milestones, and watchlists or alerts to keep relevant tickers and keywords visible. The workflow still requires independent research and judgment.

## Frequently Asked Questions

### Who is this workflow for?

It is designed for biotech newsletter writers and adjacent biotech research users who need a repeatable, source-linked way to complete this task.

### What should this workflow produce?

A staged editorial plan covering pre-conference previews, presentation-day updates, competitive synthesis, and post-meeting follow-up.

### What is the practical benefit?

The publication covers fewer but more consequential stories and gives readers continuity across the full conference information cycle.

## Related Workflows

- [How Biotech Writers Build a Daily News Briefing](https://biopharmsignal.com/use-cases/biotech-newsletter-writers/daily-biotech-newsletter-briefing.md)
- [How Newsletter Writers Build a Weekly Biotech Catalyst Roundup](https://biopharmsignal.com/use-cases/biotech-newsletter-writers/weekly-biotech-catalyst-roundup.md)
- [Avoid repeating company press releases](https://biopharmsignal.com/use-cases/biotech-newsletter-writers/avoid-repeating-company-press-releases.md)

Format note: This is an illustrative workflow guide, not a named customer testimonial or a claim of investment performance.